CVRx (CVRX) Competitors $6.04 +0.16 (+2.72%) Closing price 07/1/2025 04:00 PM EasternExtended Trading$6.22 +0.18 (+2.98%) As of 08:22 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CVRX vs. EMBC, AVNS, RXST, BVS, BFLY, KIDS, DCTH, AXGN, SMLR, and TMCIShould you be buying CVRx stock or one of its competitors? The main competitors of CVRx include Embecta (EMBC), AVANOS MEDICAL (AVNS), RxSight (RXST), Bioventus (BVS), Butterfly Network (BFLY), OrthoPediatrics (KIDS), Delcath Systems (DCTH), AxoGen (AXGN), Semler Scientific (SMLR), and Treace Medical Concepts (TMCI). These companies are all part of the "medical equipment" industry. CVRx vs. Its Competitors Embecta AVANOS MEDICAL RxSight Bioventus Butterfly Network OrthoPediatrics Delcath Systems AxoGen Semler Scientific Treace Medical Concepts CVRx (NASDAQ:CVRX) and Embecta (NASDAQ:EMBC) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability. Do institutionals & insiders hold more shares of CVRX or EMBC? 75.3% of CVRx shares are held by institutional investors. Comparatively, 93.8% of Embecta shares are held by institutional investors. 18.9% of CVRx shares are held by insiders. Comparatively, 0.4% of Embecta shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the media refer more to CVRX or EMBC? In the previous week, Embecta had 2 more articles in the media than CVRx. MarketBeat recorded 5 mentions for Embecta and 3 mentions for CVRx. CVRx's average media sentiment score of 1.07 beat Embecta's score of 0.44 indicating that CVRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Embecta 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Which has higher valuation & earnings, CVRX or EMBC? Embecta has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Embecta, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCVRx$51.29M3.07-$59.97M-$2.18-2.77Embecta$1.12B0.53$78.30M$0.9011.40 Do analysts prefer CVRX or EMBC? CVRx currently has a consensus price target of $14.50, suggesting a potential upside of 140.07%. Embecta has a consensus price target of $19.33, suggesting a potential upside of 88.43%. Given CVRx's stronger consensus rating and higher possible upside, analysts plainly believe CVRx is more favorable than Embecta.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CVRx 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.71Embecta 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Is CVRX or EMBC more profitable? Embecta has a net margin of 4.89% compared to CVRx's net margin of -97.49%. Embecta's return on equity of -19.67% beat CVRx's return on equity.Company Net Margins Return on Equity Return on Assets CVRx-97.49% -79.04% -42.37% Embecta 4.89%-19.67%12.27% Which has more risk and volatility, CVRX or EMBC? CVRx has a beta of 1.23, meaning that its stock price is 23% more volatile than the S&P 500. Comparatively, Embecta has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500. SummaryEmbecta beats CVRx on 9 of the 16 factors compared between the two stocks. Get CVRx News Delivered to You Automatically Sign up to receive the latest news and ratings for CVRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CVRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CVRX vs. The Competition Export to ExcelMetricCVRxMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$153.31M$6.78B$5.48B$8.94BDividend YieldN/A1.04%5.38%4.12%P/E Ratio-2.7727.0626.2119.74Price / Sales3.0785.89395.51109.12Price / CashN/A21.0536.4957.06Price / Book2.064.707.915.37Net Income-$59.97M$173.18M$3.15B$248.34M7 Day Performance3.42%0.20%0.77%1.67%1 Month Performance-6.79%-1.11%3.46%4.56%1 Year Performance-48.73%24.36%34.61%18.42% CVRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CVRXCVRx2.7237 of 5 stars$6.04+2.7%$14.50+140.1%-48.4%$153.31M$51.29M-2.77160Positive NewsEMBCEmbecta4.4538 of 5 stars$9.82+0.5%$19.33+96.9%-15.6%$570.98M$1.12B10.912,100AVNSAVANOS MEDICAL2.3924 of 5 stars$12.09-0.4%N/A-36.6%$561.40M$687.80M-1.442,227RXSTRxSight2.6599 of 5 stars$13.54-0.5%$37.90+179.9%-76.9%$553.07M$139.93M-20.21220Positive NewsBVSBioventus3.382 of 5 stars$6.52-0.5%$14.33+119.8%+21.6%$535.58M$567.70M-10.691,200BFLYButterfly Network2.2512 of 5 stars$2.05-1.4%$4.00+95.1%+118.5%$514.36M$82.06M-7.07460News CoverageAnalyst ForecastKIDSOrthoPediatrics4.2469 of 5 stars$20.59+1.5%$35.83+74.0%-22.5%$492.77M$204.73M-11.77200Positive NewsDCTHDelcath Systems3.3324 of 5 stars$13.26-4.3%$24.00+81.0%+54.5%$482.34M$53.85M-26.5260AXGNAxoGen2.6802 of 5 stars$9.79+0.6%$22.20+126.8%+42.2%$443.14M$187.34M-65.26450Positive NewsSMLRSemler Scientific2.3021 of 5 stars$41.99+16.2%$71.00+69.1%+5.0%$403.02M$56.29M-16.09120High Trading VolumeTMCITreace Medical Concepts2.4716 of 5 stars$5.74+4.2%$10.16+77.0%-7.2%$346.52M$209.36M-6.75250Positive News Related Companies and Tools Related Companies EMBC Competitors AVNS Competitors RXST Competitors BVS Competitors BFLY Competitors KIDS Competitors DCTH Competitors AXGN Competitors SMLR Competitors TMCI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CVRX) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CVRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CVRX Stock Alerts